Spectrum Pharmaceuticals Net Tangible Assets

Spectrum Pharmaceuticals (SPPI) currently reports a net tangible assets of $27M as of March 2023. That compares with $55M in the prior-year period — down 51.5% year over year. Use the charts on this page to explore Spectrum Pharmaceuticals's net tangible assets history and peer comparisons.

Spectrum Pharmaceuticals's net tangible assets decreased from $55M to $27M — a 51.5% year-over-year decrease (period ending March 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Spectrum Pharmaceuticals reported $27M in net tangible assets as of March 2023. That compares with $55M in the prior-year period — down 51.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $27M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Spectrum Pharmaceuticals, and consider following SPPI for alerts when major investors trade the stock.

Spectrum Pharmaceuticals is classified in the Healthcare sector. On net tangible assets, it currently shows $27M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SPPI with unrelated industries.